Contineum Therapeutics, Inc. (CTNM) › RevenueContineum Therapeutics, Inc. (CTNM) — RevenueAnnual figures by fiscal year, from SEC filings.2023: $50.00M2024: $0$02023Revenue (USD)2024Fiscal YearRevenueChange YoY2024$0-100.0%2023$50.00M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share